The Analysis Study of Histopathologic Diagnosis of Metastatic Basal Cell Carcinoma of Skin: A Comprehensive Systematic Review

The Analysis Study of Histopathologic Diagnosis of Metastatic Basal Cell Carcinoma of Skin: A Comprehensive Systematic Review

Authors

  • Wahyu Agus Prastyo Faculty of Medicine, Sultan Agung Islamic University, Semarang City, Central Java, Indonesia
  • Artha Investari Nugraheni Faculty of Medicine, Sultan Agung Islamic University, Semarang City, Central Java, Indonesia
  • Mutia Ruliana Ayuningrum Faculty of Medicine, Sultan Agung Islamic University, Semarang City, Central Java, Indonesia

Keywords:

basal cell carcinoma, metastatic, histopathologic

Abstract

Background: Metastatic basal cell carcinoma (MBCC) occurs at an exceedingly low rate, with an estimated incidence of 0.0028%, or 28 cases per 1,000,000 BCC diagnoses. The biological mechanisms underlying the metastatic potential of BCC remain poorly understood. This systematic review aims to evaluate the histopathologic features of MBCC based on literatures of the last 10 years. Methods: The study adhered to PRISMA 2020 standards, examining English literature from 2014 to 2024. It excluded editorials, reviews from the same journal, and submissions without a DOI. PubMed, SagePub, SpringerLink, and Google Scholar were utilized as literature sources. Result: Initially retrieving 360 articles from online databases (PubMed, SagePub, SpringerLink and Google Scholar) eight relevant papers were selected after three rounds of screening for full-text analysis. Conclusion: Histopathologic diagnosis of metastatic basal cell carcinoma is crucial for determining tumor type, assessment of invasion depth, examination of excised margins, and identification of lymphovascular or perineural invasion. Molecular analysis can reveal mutations influencing tumor behavior and treatment resistance.

References

Vornicescu C, Șenilă SC, Bejinariu NI, et al. Predictive factors for the recurrence of surgically excised basal cell carcinomas: A retrospective clinical and immunopathological pilot study. Exp Ther Med. 2021;22(5):1336. doi:10.3892/etm.2021.10771

Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer Oxf Engl 1990. 2019;118:10-34. doi:10.1016/j.ejca.2019.06.003

Dyalram D, Caldroney S, Heath J. Margin Analysis: Cutaneous Malignancy of the Head and Neck. Oral Maxillofac Surg Clin N Am. 2017;29(3):341-353. doi:10.1016/j.coms.2017.04.001

Bichakjian C, Armstrong A, Baum C, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540-559. doi:10.1016/j.jaad.2017.10.006

Kiely JR, Patel AJK. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin. J Plast Reconstr Aesthetic Surg JPRAS. 2019;72(11):1805-1812. doi:10.1016/j.bjps.2019.06.002

Lin Z, Qidwai U, Igali L, Hemmant B. A multicentre review of the histology of 1012 periocular basal cell carcinomas. Eur J Ophthalmol. 2021;31(5):2699-2704. doi:10.1177/1120672120957597

Armstrong LTD, Magnusson MR, Guppy MPB. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis. J Plast Reconstr Aesthet Surg. 2017;70(12):1738-1745. doi:10.1016/j.bjps.2017.04.006

Li CL, Chen YC, Yang KC, Chen LW. Different histopathologic profiles and outcomes between sun-exposed BCC and non-sun-exposed BCC. Sci Rep. 2020;10(1):7387. doi:10.1038/s41598-020-64391-9

Knani L, Romdhane O, Ben Rayana N, Mahjoub H, Ben Hadj Hamida F. [Clinical study and risk factors for recurrence of basal cell carcinoma of the eyelid: results of a Tunisian series and review of the literature]. J Fr Ophtalmol. 2014;37(2):107-114. doi:10.1016/j.jfo.2013.05.028

Furlan K, Reddy V, Alabkaa A, Rohra P, Mir F, Gattuso P. Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study. Arch Dermatol Res. 2021;313(6):439-443. doi:10.1007/s00403-020-02120-y

Hasan A, Rabie A, Elhussiny M, et al. Recurrent cutaneous basal cell carcinoma after surgical excision: A retrospective clinicopathological study. Ann Med Surg. 2022;78. doi:10.1016/j.amsu.2022.103877

Mochel MC, Liaquat S, Moore JB, Hoang MP. Metastasizing basal cell carcinoma: A clinicopathologic and immunohistochemical study of 22 cases. J Cutan Pathol. 2021;48(3):374-383. doi:10.1111/cup.13888

George RM, Nazeer M, Criton S, Abraham UM, Francis A. Clinicopathological analysis of basal cell carcinoma – A retrospective study. J Skin Sex Transm Dis. 2021;3(1):51-55. doi:10.25259/JSSTD_26_2020

Camela E, Ilut Anca P, Lallas K, et al. Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes. Medicina (Mex). 2023;59(2):349. doi:10.3390/medicina59020349

Verkouteren BJA, Wakkee M, van Geel M, et al. Molecular testing in metastatic basal cell carcinoma. J Am Acad Dermatol. 2021;85(5):1135-1142. doi:10.1016/j.jaad.2019.12.026

Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. 2020;83(3):832-838. doi:10.1016/j.jaad.2019.09.075

Laga AC, Schaefer IM, Sholl LM, French CA, Hanna J. Metastatic Basal Cell Carcinoma: Molecular Ancillary Testing and Reappraisal of Histopathology Within a Rare Entity. Am J Clin Pathol. 2019;152(6):706-717. doi:10.1093/ajcp/aqz089

Downloads

Published

2024-07-29

How to Cite

Prastyo, Wahyu Agus, Artha Investari Nugraheni, and Mutia Ruliana Ayuningrum. 2024. “The Analysis Study of Histopathologic Diagnosis of Metastatic Basal Cell Carcinoma of Skin: A Comprehensive Systematic Review”. The International Journal of Medical Science and Health Research 2 (4): 65-82. https://doi.org/10.70070/v0ay6990.